NCT05146037

Brief Summary

The study aims to evaluate the processes of a pilot single-centre randomised controlled trial (RCT) of carbon-dioxide flushing of transcatheter aortic valves (TAVI-CO2) versus standard saline flushing of valves (TAVI-S) and assess potential neuroprotection through a number of neurological endpoints for planning of a full-sized RCT

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
120

participants targeted

Target at P75+ for not_applicable stroke

Timeline
Completed

Started Sep 2021

Typical duration for not_applicable stroke

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 1, 2021

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

November 11, 2021

Completed
25 days until next milestone

First Posted

Study publicly available on registry

December 6, 2021

Completed
2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2023

Completed
Last Updated

January 26, 2023

Status Verified

January 1, 2023

Enrollment Period

2.2 years

First QC Date

November 11, 2021

Last Update Submit

January 25, 2023

Conditions

Keywords

StrokeAortic Valve StenosisSilent Cerebral InfarctVascular Brain InjuryTAVITranscatheter aortic valve implantationTranscranial dopplerMagnetic resonance imagingCO2Carbon dioxide

Outcome Measures

Primary Outcomes (1)

  • Number of participants suitable for recruitment for larger RCT

    Conduct an evaluation of the processes described in this pilot RCT for a full-scale RCT including: 1. Screening, Recruitment and Randomisation 2. Retention in follow-up assessments 3. Study design for a full RCT and identification of important stratification variables 4. Refine sample size calculation for a full RCT

    Duration of study, approximately 15 months

Secondary Outcomes (1)

  • Incidence of Vascular Brain Injury (VBI) on Diffusion Weighted-Magnetic Resonance Imaging (DW-MRI)

    Post TAVI 1-7 days and 6-months post TAVI

Other Outcomes (4)

  • Detection of periprocedural cerebral solid and gaseous emboli

    During TAVI procedure

  • Neurological deficit

    6 Months

  • Inflammatory biomarker assessing brain injury

    24 hours post TAVI

  • +1 more other outcomes

Study Arms (2)

Saline flushing

ACTIVE COMPARATOR

TAVI valves will be prepared according to instruction for use(IFU) with saline flushing only.

Other: Saline flushing

CO2 and saline flushing

EXPERIMENTAL

TAVI valves will be flushed with CO2 and then saline as per IFU

Other: CO2 and saline flushing

Interventions

TAVI valves will be prepared by flushing with CO2 to displace any retained air during manufacturing and preparation. The valves will then be flushed with saline as per IFU.

CO2 and saline flushing

TAVI valves will be flushed with saline only as per IFU.

Saline flushing

Eligibility Criteria

Age18 Years - 100 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • All patients between the ages of 18 and 100 years undergoing transcatheter aortic valve implantation (TAVI) for aortic stenosis under local anaesthetic.

You may not qualify if:

  • Patients that lack capacity to provide informed consent
  • Patients that have had a stroke within 12 months
  • Patients aged less than 18 years of age
  • Patients that are pregnant

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Imperial College London

London, United Kingdom

RECRUITING

Related Publications (5)

  • Inci K, Koutouzi G, Chernoray V, Jeppsson A, Nilsson H, Falkenberg M. Air bubbles are released by thoracic endograft deployment: An in vitro experimental study. SAGE Open Med. 2016 Dec 7;4:2050312116682130. doi: 10.1177/2050312116682130. eCollection 2016.

    PMID: 27994872BACKGROUND
  • Rohlffs F, Tsilimparis N, Saleptsis V, Diener H, Debus ES, Kolbel T. Air Embolism During TEVAR: Carbon Dioxide Flushing Decreases the Amount of Gas Released from Thoracic Stent-Grafts During Deployment. J Endovasc Ther. 2017 Feb;24(1):84-88. doi: 10.1177/1526602816675621. Epub 2016 Oct 26.

    PMID: 27798380BACKGROUND
  • Martens S, Neumann K, Sodemann C, Deschka H, Wimmer-Greinecker G, Moritz A. Carbon dioxide field flooding reduces neurologic impairment after open heart surgery. Ann Thorac Surg. 2008 Feb;85(2):543-7. doi: 10.1016/j.athoracsur.2007.08.047.

    PMID: 18222261BACKGROUND
  • Bismuth J, Garami Z, Anaya-Ayala JE, Naoum JJ, El Sayed HF, Peden EK, Lumsden AB, Davies MG. Transcranial Doppler findings during thoracic endovascular aortic repair. J Vasc Surg. 2011 Aug;54(2):364-9. doi: 10.1016/j.jvs.2010.12.063. Epub 2011 Mar 3.

    PMID: 21371850BACKGROUND
  • Perera AH, Rudarakanchana N, Monzon L, Bicknell CD, Modarai B, Kirmi O, Athanasiou T, Hamady M, Gibbs RG. Cerebral embolization, silent cerebral infarction and neurocognitive decline after thoracic endovascular aortic repair. Br J Surg. 2018 Mar;105(4):366-378. doi: 10.1002/bjs.10718. Epub 2018 Feb 12.

    PMID: 29431856BACKGROUND

MeSH Terms

Conditions

StrokeAortic Valve StenosisCerebrovascular Trauma

Condition Hierarchy (Ancestors)

Cerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesVascular DiseasesCardiovascular DiseasesAortic Valve DiseaseHeart Valve DiseasesHeart DiseasesVentricular Outflow ObstructionTrauma, Nervous SystemWounds and Injuries

Study Officials

  • Ghada Mikhail

    Imperial College London

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Saud Ahmed Khawaja, MBBS

CONTACT

Ghada Mikhail, MD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Masking Details
Patients and outcome assessors will be blinded to intervention.
Purpose
PREVENTION
Intervention Model
PARALLEL
Model Details: Patients will be randomised to CO2 and Saline flushing versus saline flushing only.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 11, 2021

First Posted

December 6, 2021

Study Start

September 1, 2021

Primary Completion

December 1, 2023

Study Completion

December 1, 2023

Last Updated

January 26, 2023

Record last verified: 2023-01

Locations